These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Therapy results with nalidixic acid in chronic urinary tract infection]. Broghammer H. Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373 [No Abstract] [Full Text] [Related]
4. [Blood level kinetics of carbenicillin]. Simon C, Hamacher A, Malerczyk V, Rohwedder HJ. Arzneimittelforschung; 1971 Jan; 21(1):78-85. PubMed ID: 4929247 [No Abstract] [Full Text] [Related]
5. [Nalidixic acid]. Wójcicki J. Wiad Lek; 1967 Jan 01; 20(1):23-5. PubMed ID: 5342349 [No Abstract] [Full Text] [Related]
6. Treatment of pyelonephritis with aztreonam: kinetic study in children. Kafetzis D, Papadimitriou G, Stavridis C, Sinaniotis C, Papoulias G. Chemioterapia; 1987 Jun 01; 6(2 Suppl):284-5. PubMed ID: 3334567 [No Abstract] [Full Text] [Related]
7. [Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis]. Prát V, Konícková L, Ritzerfeld W, Losse H. Arztl Forsch; 1968 Feb 10; 22(2):69-72. PubMed ID: 4876157 [No Abstract] [Full Text] [Related]
8. [Treatment with carbenicillin (Pyopen) of severe general infectious and pyelonephritis due to Pseudomonas aeruginosa and Proteus]. Liwski R, Gietko G. Pol Arch Med Wewn; 1969 Sep 10; 43(3):1311-9. PubMed ID: 4900790 [No Abstract] [Full Text] [Related]
9. [The effect of combinations of antibacterial preparations on resistant strains of pyelonephritis agents]. Sukhodol'skaia AE, Chaĭkovskaia VL. Antibiotiki; 1974 Jul 10; 19(7):630-3. PubMed ID: 4618771 [No Abstract] [Full Text] [Related]
10. [Nalidixic acid sensitivity of an E. coli strain in experimental pyelonephritis]. Hatala M, Ritzerfeld W, Prát V, Konicková L. Arch Hyg Bakteriol; 1969 Jun 10; 153(3):254-9. PubMed ID: 4908403 [No Abstract] [Full Text] [Related]
11. Pyelonephritis in the mouse. 3. Therapeutic experiments. FitzPatrick FK, Bladzinski J. Proc Soc Exp Biol Med; 1968 Apr 10; 127(4):1180-5. PubMed ID: 4297698 [No Abstract] [Full Text] [Related]
14. [Trimethoprim and sulfamethoxazole (Eusaprim) in chronic urinary tract infections]. Porpáczy P. Wien Klin Wochenschr; 1971 Jun 18; 83(24):439-41. PubMed ID: 4942385 [No Abstract] [Full Text] [Related]
15. [Determination of bacterial sensitivity to neggram from the aspect of its clinical use]. Chernomordik AB. Urol Nefrol (Mosk); 1971 Jun 18; 36(5):63-5. PubMed ID: 4946794 [No Abstract] [Full Text] [Related]
16. Evaluation of the antibacterial effect of nalidixic acid in two experimental models of Escherichia coli pyelonephritis. Prát V, Konícková L, Hatala M, Urbanová D. Br J Exp Pathol; 1968 Feb 18; 49(1):60-7. PubMed ID: 4867859 [No Abstract] [Full Text] [Related]
17. Piromidic acid and beta-hydroxypiromidic acid: therapeutic effectiveness on experimental E. coli pyelonephritis in the rat. Loew H, Ritzerfeld W. Int J Clin Pharmacol; 1973 Apr 18; 7(2):234-7. PubMed ID: 4581342 [No Abstract] [Full Text] [Related]
18. Ofloxacin: therapeutic activity in experimental infections. Guerra L, Erani E, Xerri L. Chemioterapia; 1986 Dec 18; 5(6):375-8. PubMed ID: 3467874 [Abstract] [Full Text] [Related]
19. [Prophylaxis of urinary tract infections in rats by long-term chemotherapy]. Prát V, Konícková L, Ritzerfeld W, Losse H. Int Z Klin Pharmakol Ther Toxikol; 1969 Jan 18; 2(1):26-9. PubMed ID: 4894945 [No Abstract] [Full Text] [Related]
20. Nalidixic acid in chronic urinary-tract infections in children. Lorber J. Practitioner; 1967 May 18; 198(187):684-7. PubMed ID: 6047161 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]